Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 62332-083

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 62332-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valsahctz 160 12 5mg

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/12.5 mg film-coated tablets by Alembic Pharmaceuticals Inc. The box contains 30 tablets. The label includes dosage strength, storage instructions, barcode, and dispensing information, indicating prescription use only.*

FDA Label Image

30's Bottle Pack (Valsahctz 160 25mg)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg film-coated tablets by Alembic Pharmaceuticals Inc. The label includes the NDC 62332-081-30, storage instructions, a barcode, and information indicating 30 tablets per bottle with a cautioned dispensing notice for pharmacists. Manufacturing locations in India and the USA are noted.*

FDA Label Image

Valsahctz 320 12 5mg

Label for Valsartan and Hydrochlorothiazide Tablets, USP with a strength of 320 mg/12.5 mg. The film-coated oral tablets are supplied by Alembic Pharmaceuticals Inc. This 90-tablet package includes usage, storage instructions, and mentions dispensing with patient information leaflet. The label also displays the NDC number 62332-082-90 and includes a barcode.*

FDA Label Image

30's Bottle Pack (Valsahctz 320 25mg)

Label for Valsartan and Hydrochlorothiazide tablets, USP 320 mg/25 mg, film-coated oral tablets. The label indicates 30 tablets per package, prescription only, and is manufactured by Alembic Pharmaceuticals Inc. Storage instructions and a barcode are also visible on the label.*

FDA Label Image

Valsahctz 80 12 5mg

Packaging label for Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5 mg, film-coated tablets by Alembic Pharmaceuticals Inc. The label includes dosage information, storage instructions, manufacturer details, a barcode, and a statement indicating 30 tablets per bottle. The label is primarily white with blue and purple highlighting the strength.*

FDA Label Image

Figure 1 (Valsahctz Figur1)

A line graph displaying the probability of achieving systolic blood pressure (SBP) under 140 mmHg at week 8, based on baseline SBP levels from 140 to 180 mmHg. The graph compares four groups: Valsartan and hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, showing higher probabilities for the combination tablet across all baseline SBP values.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs showing probabilities of achieving specific blood pressure targets at Week 8 with Valsartan and Hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The charts depict probability versus Baseline DBP or SBP levels for achieving diastolic blood pressure <90 mmHg, systolic blood pressure <130 mmHg, and diastolic blood pressure <80 mmHg, respectively.*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure diagram of the active ingredient Valsartan and Hydrochlorothiazide showing its molecular composition with labeled functional groups and chemical bonds.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure of Valsartan, one of the active ingredients in Valsartan and Hydrochlorothiazide tablets. The diagram shows the molecular arrangement and bonding of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.